In summary, a deepened understanding of the metabolic roles of CDK4/6 will open up avenues for the diagnosis of and metabolic interventions against KSHV malignancies and cancers with dysregulated Cyclin D/CDK4/CDK6 activities. The gene discussed is CDK6; the disease is cancer.